[DISCLOSURE] Access Bio (950130) -- which specializes in research, development and manufacturing of in vitro rapid diagnostic tests, biosensor and molecular diagnostic products -- has received 2 billion won (US$ 1.82 million) from the Bill & Melinda Gates Foundation.

The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)